![Floor Stam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Floor Stam active positions
Companies | Position | Start | End |
---|---|---|---|
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Corporate Officer/Principal | - | - |
Founder | 2019-12-31 | - | |
Chief Operating Officer | 2019-12-31 | - |
Career history of Floor Stam
Statistics
International
Belgium | 2 |
Operational
Chief Operating Officer | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Commercial Services |
- Stock Market
- Insiders
- Floor Stam
- Experience